Venrock Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
31
- Investments
-
1,117
- Portfolio
-
118
- Exits
-
537
Venrock General Information
Company Description
Founded in 1969, Venrock is a venture capital firm based in Palo Alto, California. The firm seeks to invest in companies operating in the cybersecurity, defense & aerospace, security & infrastructure, financial technology, technology, healthcare, life sciences, software-as-a-service, and artificial intelligence sectors based in the United States region.
Business Details
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 3340 Hillview Avenue
- Silicon Valley
- Palo Alto, CA 94304
- United States
Venrock Investments & Acquisitions (1,117)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Mentari Therapeutics | 06-Nov-2026 | PIPE | Drug Discovery | Generating Revenue | ||
| Mentari Therapeutics | 06-Nov-2026 | Drug Discovery | Generating Revenue | |||
| Suki | 13-Oct-2026 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Velaris Therapeutics | 13-Oct-2026 | Drug Discovery | Generating Revenue | |||
| KymaThera | 06-Oct-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Korsana Biosciences | 07-Sep-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Aligned Marketplace | 13-Aug-2026 | Managed Care | Generating Revenue | |||
| Avere Therapeutics | 10-Aug-2026 | Drug Discovery | Generating Revenue | |||
| Expedition Therapeutics | 05-Aug-2026 | Early Stage VC | Biotechnology | Clinical Trials - Phase 2 | ||
| Encoded | 04-Aug-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
Venrock Exits (537)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Lycia Therapeutics | 23-Oct-2026 | IPO | |
| Devoted | 01-Oct-2026 | ||
| ADARx Pharmaceuticals | 25-Sep-2026 | ||
| Crescent Biopharma | 16-Jul-2026 | ||
| Stride Health | 08-Jul-2026 | ||
| Abivax | 06-Jul-2026 | ||
| Kelonia | 26-Jun-2026 | ||
| Cybin | 25-Jun-2026 | ||
| Enliven Therapeutics | 11-Jun-2026 | Public Investment 2nd Offering | |
| Jade Biosciences | 03-Jun-2026 | Public Investment 2nd Offering |
Venrock Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Venrock Investments by Industry, Year, and Region
Venrock Co-Investors (418)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Fidelity Management & Research Company | 10 |
|
|
||
| RA Capital Management |
|
|
|||
| OrbiMed |
|
|
|||
| Invus (Private Equity) |
|
|
|||
| Forbion |
|
|
Venrock FAQs
-
What is Venrock?
Founded in 1969, Venrock is a venture capital firm based in Palo Alto, California.
-
When was Venrock founded?
Venrock was founded in 1969.
-
Where is Venrock headquartered?
Venrock is headquartered in Palo Alto, CA.
-
What is Venrock's total asset value?
Venrock has around in total assets under management.
-
How many investments has Venrock made?
Venrock has made 1,117 investments.
-
What has Venrock invested in?
Venrock has made numerous investments in companies like Mentari Therapeutics, Suki, and Velaris Therapeutics within the Drug Discovery and Enterprise Systems (Healthcare) industries.
-
What has Venrock invested in recently?
Venrock's latest investment was on 06-Nov-2026 in Mentari Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process